JAGSNPHARM.BO

Compare

No price history available for this symbol yet.

Fair-value model

Consensus-seeded revenue, margins, and exit multiples. This is a scenario tool, not investment advice.

Years of analysisAssumption entries

Analyst estimates unavailable for this ticker.

Held by

portfolios on TandT

Bookmarked by

users

Avg position size

—

of holders' portfolios

13F filers

institutions

Sector

Drug Manufacturers - Specialty & Generic

DCF fair valuemodel estimate

Intrinsic value

$370.78

Price

$224.83

Implied upside

+65%

Peer comparison

Symbol	Price	Today	Mkt cap	P/E
JAGSNPHARM.BOJagsonpal Pharmaceuticals Limited	$228.10	+1.11%	$15.0B	—
BAJAJHCARE.BOBajaj Healthcare Ltd	$320.95	+0.19%	$10.7B	—
BAJAJHCARE.NSBajaj Healthcare Ltd	$321.10	+0.06%	$10.8B	—
BLISSGVS.BOBliss GVS Pharma Limited	$679.90	-0.94%	$72.5B	—
BLISSGVS.NSBliss GVS Pharma Limited	$680.50	-0.65%	$72.2B	—
HESTERBIO.BOHester Biosciences Limited	$2184.70	+0.78%	$18.6B	—
HESTERBIO.NSHester Biosciences Limited	$2207.70	+1.65%	$18.8B	—

Source: Financial Modeling Prep · peers by sector/industry

Jagsonpal Pharmaceuticals Limited

Jagsonpal Pharmaceuticals Limited specializes in the manufacturing and global supply of pharmaceutical products and active pharmaceutical ingredients (APIs). The company's primary therapeutic focus spans women's health, pain management, and general medical conditions, serving markets both within India and internationally. Its extensive product range includes both prescription formulations and over-the-counter medications, specifically addressing gynaecological, orthopaedic, and allergy-related needs. These pharmaceutical offerings are available in various dosage forms such as tablets, softgels, injectable solutions, capsules, and oral syrups. The firm, established in 1978, is headquartered in New Delhi, India.

www.jagsonpal.com

Employees: 1,297
IPO / List date: Nov 27, 2001
HQ: IN

Held by traders on TradeandTell

No one on the platform currently holds JAGSNPHARM.BO.

Super investors & insiders

Institutions holding (13F)

No tracked institution reports a position in JAGSNPHARM.BO as of their last filing.

Insider activity (SEC Form 4)

No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.

Insider activity (SEC Form 4)

Recent trades on TradeandTell

No one on the platform has traded JAGSNPHARM.BO yet.